Clinical Trial Update: Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial evaluating tolcapone as a cognitive enhancer in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Tolcapone (tolcapone)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Schizophrenia | Phase 2 | Status: UNKNOWN